openPR Logo
Press release

ASCENTA 4.0 showcased at NASSCOM’s Product Launchpad 2010

11-17-2010 10:01 AM CET | Science & Education

Press release from: Ocimum Biosolutions

Gaithersburg, Maryland, US and Hyderabad, Andhra Pradesh, India.

As a prelude to NASSCOM’s Product Conclave in Bangalore, 10 Companies were chosen to showcase new products at an exclusive interactive session with the media/blogger community. Of over 50 entries received, Ocimum Biosolutions’ new version of the ASCENTA® system was chosen in the top 10 to showcase its new features.

The ASCENTA® System has been providing a fast, easy, and affordable way to assess, prioritize, and qualify gene targets and potential biomarkers for over seven years. However, in a constant effort to provide better service, the interface is being upgraded from its current version 3.5 to 4.0 in December 2010. There is much to look forward for the research community in pharma, biotech and related academia from ASCENTA 4.0 as it comes fully loaded with more data and improved features that enhance user experience and yield better results.

About ASCENTA system:
ASCENTA was conceived to simplify access and information retrieval from BioExpress, a comprehensive gene expression database. Ascenta is the reference software product that makes it possible for researchers to quickly identify and prioritize drug targets with respect to specific therapeutic and large-scale human biological considerations. In the past seven years Ascenta has been instrumental in the discovery and validation of several drug targets.

About Ocimum Biosolutions

Ocimum Biosolutions is an leading integrated global genomics outsourcing partner with solutions spanning Bioresearch Design and Execution; Data Analytics and Insights; Laboratory, Sample & Data Management; and Integrated Solutions. Ocimum provides comprehensive genomic services and reference databases; data analysis; biorepository services such as sample accrual & collection, IRB approvals, CRO training, sample, clinical data capture and management; life science lab information management solutions; and also offers both research level and GLP-compliant services. Majority of the top 25 pharma & biotech companies and leading research institutes worldwide have chosen Ocimum as their preferred genomics outsourcing partner

For more information, please visit www.ocimumbio.com.

Ocimum Biosolutions

Ocimum Biosolutions Ltd.
6th Floor, Reliance Classic
Road No. 1, Banjara Hills
Hyderabad - 500 034. A.P., India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ASCENTA 4.0 showcased at NASSCOM’s Product Launchpad 2010 here

News-ID: 152090 • Views:

More Releases from Ocimum Biosolutions

Sciantis™ – Ocimum Biosolutions unveils its new software product to handle B …
cimum Biosolutions announces release of its new software product, Sciantis™, a lab process and data management platform for biologics labs. Sciantis™ helps Labs to manage Biologics development process, automate data capturing and support lab Analytics needs. Mr. Subash Lingareddy, CFO, President of Ocimum Biosolutions, said, “Sciantis™ is our new software offering to serve Biologics companies in improving their development process and data management. This software also serves
Ocimum Biosolutions Is Winner of Bioexcellence Award ( Bioinformatics and Systems Biology) at Bio India 2012
Ocimum Biosolutions Is Winner of Bioexcellence Award ( Bioinformatics and System …
Hyderabad, Andhra Pradesh, India, February 07th, 2012: The Jury of Industry experts constituted by ABLE has declared Ocimum Biosolutions as a Bioexcellence Award winner at Bio INDIA BIO 2012 event under Bioinformatics & Systems Biology Category. Ms. Anuradha Acharya, CEO of Ocimum Biosolutions said, “Systems Biology and Bioinformatics will be the backbone of future therapeutics and diagnostics. At Ocimum we are focusing our efforts in these areas to meet the needs of the

More Releases for ASCENTA

Omega 3 Products- A Market Worth Observing Growth: Cargill, Pharmavite, Ascenta …
Global Omega 3 Products Market Growth 2021-2026 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Omega 3 Products Market. Some of the key players profiled in the study are Epax, Aker BioMarine, Innovix
Global Omega 3 Products Market 2017- PharmavTechnologye, KD Pharma, Ascenta Heal …
Global Omega 3 Products Market 2017, presents a professional and in-depth study on the current state of the Omega 3 Products market globally, providing basic overview of Omega 3 Products market including definitions, classifications, applications and industry chain structure. Historical data available in the report elaborates on the development of the Omega 3 Products market on a global and regional level. The report compares this data with the current Omega
Market Volatility Trims Healthy First Quarter Gain – Ascenta Special Situation …
April 23, 2012 - Ascenta Asset Management, a licensed portfolio manager and investment advisor to the Ascenta Special Situations Resource Fund, recently released their market commentary for their Special Situations Resource Fund for the month of March 2012. The market commentary is written by Jason Cubbit, Managing Director Fund Services. “March saw an end to the recent rally as weaker economic data from China and Europe captured the market’s attention, and
US Recovery Drives 10% Rise in January – Ascenta Special Situations Resource F …
March 6, 2012 -Ascenta Asset Management, a licensed portfolio manager and investment advisor to the Ascenta Special Situations Resource Fund, recently released their market commentary for their Special Situations Resource Fund for the month of January 2012. The market commentary is written by Jason Cubbit, Managing Director Fund Services. “January saw a continued US equities recovery with the Dow Jones rising over 15% since October 1st. This was despite the European
Ascenta Asset Management Upgrades Website Structure and Content Management Syste …
August 2011 --- Ascenta Asset Management, a licensed portfolio manager and investment advisor to the Ascenta Special Situations Resource Fund, recently enhanced their website with a modern, streamlined design and structure accompanied by an upgrade to their website’s content management system which makes website maintenance and updates simpler and quicker. The website upgrade was part of an overall online awareness campaign of the company designed to help online visitors and searchers
Gene Logic Launches new user-friendly ASCENTA 4.0 with improved functionality
Gene Logic today announced the release of ASCENTA System Version 4.0, which incorporates a number of significant changes in functionality reinforcing its position as a valuable research tool to the academic, biotechnology and pharmaceutical markets. ASCENTA is a reference software product for use in gene expression studies. In the continuous quest to improve accessibility and provide the most comprehensive data for researchers, Gene Logic has launched this newest version, ASCENTA 4.0.